Clinical Trials Directory

Trials / Completed

CompletedNCT01012115

Coagulation Factors, Cytokines and Tissue Injury Markers in Sepsis

Temporal Behavior of Coagulation Factors,Cytokines and Tissue Injury Markers in Sepsis: Validation of Extracellular Histones

Status
Completed
Phase
Study type
Observational
Enrollment
500 (actual)
Sponsor
University of Oklahoma · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In an effort to better understand the interaction between the different mediators, the investigators propose to examine the time course of mediators, the indexes of organ injury and the coagulation cascade.

Detailed description

All patients admitted to the ICU (Including VA Medical Center, University Hospital and Presbyterian hospital) will be screened for enrollment in the study. Patients who have the diagnosis of sepsis will be asked to volunteer. We will match sepsis patients with other ICU patients without the diagnosis of sepsis. The latter will also be asked to volunteer. Patients will be stratified into three groups: * Sepsis * SIRS of non-septic origin * Other ICU patients Routine laboratory data and clinical data (see flow sheet) will be collected. The plasma or serum will be frozen separately until the target number of patients is met. Measurements of inflammatory mediators and other cytokines/injury markers will be carried out at that point.

Conditions

Timeline

Start date
2009-10-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2009-11-11
Last updated
2012-04-09

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01012115. Inclusion in this directory is not an endorsement.

Coagulation Factors, Cytokines and Tissue Injury Markers in Sepsis (NCT01012115) · Clinical Trials Directory